Ranasinghe, P., Galappaththy, P., Constantine, G. R., Jayawardena, R., Weeratunga, H. D., Premakumara, S., & Katulanda, P. (2017). Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: Study protocol for a randomized controlled trial. Current controlled trials in cardiovascular medicine, 18(1), 446-8. https://doi.org/10.1186/s13063-017-2192-0
Citácia podle Chicago (17th ed.)Ranasinghe, Priyanga, Priyadarshani Galappaththy, Godwin Roger Constantine, Ranil Jayawardena, Hasitha Dhananjaya Weeratunga, Sirimal Premakumara, a Prasad Katulanda. "Cinnamomum Zeylanicum (Ceylon Cinnamon) as a Potential Pharmaceutical Agent for Type-2 Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial." Current Controlled Trials in Cardiovascular Medicine 18, no. 1 (2017): 446-8. https://doi.org/10.1186/s13063-017-2192-0.
Citácia podľa MLA (8th ed.)Ranasinghe, Priyanga, et al. "Cinnamomum Zeylanicum (Ceylon Cinnamon) as a Potential Pharmaceutical Agent for Type-2 Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial." Current Controlled Trials in Cardiovascular Medicine, vol. 18, no. 1, 2017, pp. 446-8, https://doi.org/10.1186/s13063-017-2192-0.